1985
DOI: 10.1016/b978-0-08-033215-4.50040-6
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Cloning, Sequencing and Expression of a Cdna Coding for Human Antithrombin III

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1987
1987
1997
1997

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Thus, maturation of hATIII becomes a limiting activity above a certain threshold concentration of intracellular hATIII, which is somewhere between 0.5 and 2.1 g hATIII/10 6 cells in this system (Table I). A posttranslational modification of hATIII must occur to some extent to yield active protein, as can be concluded from unsuccessful attempts to express active hATIII in prokaryotic and lower eukaryotic hosts (Bröker et al, 1987;Dingermann et al, 1991;Colau et al, 1985;Prochownik et al, 1983). This indicates that in A11-A279-C7 cells the capability for performing early posttranslational modifications is limited to certain intracellular amounts of a recombinant protein.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, maturation of hATIII becomes a limiting activity above a certain threshold concentration of intracellular hATIII, which is somewhere between 0.5 and 2.1 g hATIII/10 6 cells in this system (Table I). A posttranslational modification of hATIII must occur to some extent to yield active protein, as can be concluded from unsuccessful attempts to express active hATIII in prokaryotic and lower eukaryotic hosts (Bröker et al, 1987;Dingermann et al, 1991;Colau et al, 1985;Prochownik et al, 1983). This indicates that in A11-A279-C7 cells the capability for performing early posttranslational modifications is limited to certain intracellular amounts of a recombinant protein.…”
Section: Discussionmentioning
confidence: 99%
“…Binding of heparin to hATIII induces a conformational change in the hATIII molecule (Einarsson and Andersson, 1977;Fish and Björk, 1979;Olson et al, 1981;Li et al, 1976;Rosenberg and Damus, 1973;Villaneuva and Danishefsky, 1977), which accelerates the reaction between hATIII and thrombin or tightens the heparinantithrombin III complex (Olson et al, 1981;Peterson and Blackburn, 1987). The cDNA for hATIII was cloned (Bock et al, 1982;Chandra et al, 1983;Colau et al, 1985;Prochownik et al, 1983) and stable expression in CHO cells (Wasley et al, 1987;Zettlmeissl et al, 1987) yielded biologically active hATIII (Zettlmeissl et al, 1987). hATIII produced in CHO cells is very similar to plasma hATIII, but shows an altered glycosylation pattern (Zettlmeissl et al, 1989) and affinity for heparin (Björk et al, 1992).…”
Section: Introductionmentioning
confidence: 99%
“…Its concentration in plasma is 2.2-2.4 i~mol/l (about 150 Ilg/ml). The antithrombin III gene (Prochownik et al 1985) and cDNA clones have been isolated and characterized (Bock et al 1982;Chandra et al 1983;Colau et al 1985;Prochownik et al 1983). The precursor molecule of antithrombin III comprises a signal peptide of 32 amino acids, which is responsible for secretion of the mature antithrombin III composed of 432 amino acids.…”
Section: Discoideummentioning
confidence: 99%
“…Several groups have succeeded in expressing the human antithrombin III gene in E. coli (Bock et al 1982;Colau et al 1985) and in different cell lines and organisms (Prochownik and Orkin 1984;Stephens et al 1987;Br6ker et al 1987;Zettlmeissl et al 1987). Two groups reported the heterologous expression of biologically active antithrombin III.…”
Section: Discoideummentioning
confidence: 99%